What is the life expectancy for people with Parkinson’s?

Health & LifestyleNews
334

Listen to article (english)

Translate to Spanish or other 102 languages!

While Parkinson’s disease itself is not fatal, complications like infections and falls can be life-threatening. Image for illustration purposes
While Parkinson’s disease itself is not fatal, complications like infections and falls can be life-threatening. Image for illustration purposes

Mega Doctor News

- Advertisement -

Medical News Today

Parkinson’s disease is a progressive disorder of the nervous system. It affects a person’s movement and mental ability, with the symptoms getting worse over time.

In this article, we discuss the life expectancy of someone with Parkinson’s, as well as the stages of the disease and the potential complications.

- Advertisement -

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/parkinsons-life-expectancy?utm_term=feedcontent&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2025-07-25&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
STC, Boys & Girls Club of McAllen open doors to high-demand careers for high school students
Next article
Using Caution with Dieting Tips from Influencers

More Articles

FDA Approves First Drug of Its Kind for Polycythemia Vera, a Rare Blood Disorder

The U.S. Food and Drug Administration today approved Mimrylo (rusfertide), a new treatment for adults with polycythemia vera, a rare blood disorder that causes the body to make too many red blood cells.

Pediatricians Urge Caution with AI Health Tools

It seems like people are using AI for everything these days, including seeking medical advice for their children, but is that actually a good idea?

Smart Strategies to Fight Childhood Obesity Today

As kids head back to school and new routines are established, pediatricians are warning of the long-term consequences of obesity.

FDA Approves First Oral Drug Indicated to Treat Dermatomyositis in Adults

Lisraya is the first FDA-approved oral treatment option for patients with dermatomyositis, addressing the high unmet need for this rare disease.
- Advertisement -